{"id":"W857806473","doi":"10.1158/1538-7445.sabcs14-p1-10-05","title":"Abstract P1-10-05: A cost utility analysis from a Chinese health care perspective of Nab-paclitaxel or docetaxel, both as alternatives to solvent-based paclitaxel in metastatic breast cancer (MBC)","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Docetaxel; Paclitaxel; Medicine; Oncology; Neutropenia; Febrile neutropenia; Internal medicine; Metastatic breast cancer; Chemotherapy; Breast cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009272213,0.001553784,0.002631921,0.003676519,0.0004800171,0.002883996,0.00170842,0.001638496,0.00782103],"category_scores_gemma":[0.01596658,0.0008789272,0.00865595,0.003246348,0.0008695016,0.001372865,0.001388589,0.002009693,0.0001974418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009953448,"about_ca_system_score_gemma":0.007780024,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03947763,"about_ca_topic_score_gemma":0.01357126,"domain_scores_codex":[0.9939412,0.004712097,0.0001847938,0.000400797,0.0003731992,0.0003878543],"domain_scores_gemma":[0.9926642,0.005731825,0.0005061172,0.0001692407,0.0005411784,0.000387492],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.01994434,0.001509126,0.07961498,0.006191351,0.02800809,0.001886516,0.0003028382,0.8002472,0.001215644,0.01096753,0.005953287,0.04415915],"study_design_scores_gemma":[0.00640012,0.006547532,0.07662678,0.001162246,0.03161241,0.0006190978,0.0009655192,0.8631866,0.0009187345,0.008268489,0.003410849,0.0002816482],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9510504,0.01521851,0.01155966,0.003651756,0.0001993558,0.001542036,0.007682228,0.00007212597,0.009024054],"genre_scores_gemma":[0.9944364,0.001068803,0.001722433,0.0002266636,0.00003585177,0.0004228803,0.001460493,0.00001173764,0.0006147482],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03947763,"threshold_uncertainty_score":0.07849574,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1695356685572058,"score_gpt":0.5457196015391899,"score_spread":0.376183932981984,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}